Top Medical News

FDA Approves Avapritinib for Rare Blood Disease

June 16th 2021

The FDA approved avapritinib (Ayvakit) for the treatment of adults with advanced systemic mastocytosis (AdvSM), including those with mast cell leukemia (MCL), aggressive systemic mastocytosism (ASM), or systemic mastocytosis with an associated hematological neoplasm (SM-AHN).

COVID-19 and the Rise of Texting in Health Care

June 16th 2021

The last thing patients want is to be put on hold or interrupted by calls at work.

New Targets May Improve the Treatment of Rare Skin Cancer

June 16th 2021

While merkel cell carcinoma (MCC) tends to have poor prognoses and limited treatment options, promising response rates with checkpoint inhibitors may pave the way for better treatment for the rare skin cancer.

Normalize the Clinical Trial Conversation

June 15th 2021

"Clinical trials are the vital bridge between research and a drug’s eventual availability to patients.The process comes to a halt if there is not enough accrual for the study to take off. This is where nurses can not only help to educate but also spread the word among their peers and patients." —Megan Price, MSN, APRN, FNP-C

Oncology Nurse Talks Pride Month, LGBTQ Disparities

June 15th 2021

After hearing about the difficulties a transgender man faced in receiving a cancer diagnosis, Kelly S. Haviland, PhD, FNP-BC, found her calling.


Most Recent